Praxis will receive an upfront payment from UCB, and if the option is exercised by UCB, would be eligible to receive an option fee and future success-based development and commercialization milestone payments, for a total of up to ~$100M, in addition to tiered royalties on net sales of any resulting products from the collaboration.
Stock up 2.3% after-hours.
FILE PHOTO: Tesla electrical automobiles are pictured at one of many firm's supply facilities in Valenton, close to Paris, France,...
After a chronic interval of muted demand weighed down by excessive possession prices, cussed inflation, and an unfavourable rate of...
Gold and silver superior as buying and selling in 2026 kicked off, constructing on their greatest annual performances since 1979.Bullion...
Folks depart flowers outdoors the "Le Constellation" bar, after a fireplace and explosion throughout a New 12 months’s Eve social...
Israeli oil and gasoline exploration partnership NewMed Vitality (TASE: NWMD), the largest companion within the Leviathan pure gasoline reservoir,...
Shares of India's largest cigarette maker, ITC, suffered their steepest single-day decline in practically six years on Thursday, with shares...
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.
